Document is current
Any future updates will be listed below
-
Authors
Lautert-Dutra, William
M. Melo, Camila
Chaves, Luiz P.
Crozier, Cheryl
P. Saggioro, Fabiano
B. dos Reis, Rodolfo
Bayani, Jane
Bonatto, Sandro L.
Squire, Jeremy A.
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/22912-8, 2019/22912-8, 2021/15011-4, 2019/22912-8)
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 24 April 2024
First Online: 4 May 2024
Declarations
:
: The retrospective data use was approved by the Ethics Committee in Research of Hospital of Ribeirão Preto, São Paulo, Brazil (HCRP) number CAAE 60032122.8.0000.5440 and the Ethics Board of the University of Toronto (Protocol: 00043323).
: The data used in the manuscript follows the Genotypes and Phenotypes (dbGaP) database guidelines for access and publication (project ID 29255).
: J.B. has the patent application “A Molecular Classifier for Personalized Risk Stratification for Patients with Prostate Cancer” under consideration. Status: PCT, Filing date: June 18, 2021, International Application No.: PCT/CA2021/050837, PCT Application Title: Molecular Classifiers for Prostate Cancer. Previous US Provisional Status: Filing Date: June 18, 2020, US Provisional Patent No. 63/040.692, US Provisional Application Title: Use of Molecular Classifiers to Diagnose, Treat, and Prognose Prostate Cancer.
